GH Research (GHRS) Other Accumulated Expenses (2021 - 2025)
GH Research (GHRS) recorded quarterly Other Accumulated Expenses of $4.2 million in Q4 2025, down 31.65% quarter-over-quarter from $6.2 million in Q3 2025, and down 14.42% on a YoY basis from $5.0 million in Q4 2024.
GH Research (GHRS) Other Accumulated Expenses (2021 - 2025) Analysis & Trends
GH Research's Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $4.2 million for Q4 2025.
- In Q4 2025, Other Accumulated Expenses fell 14.42% year-over-year to $4.2 million; the TTM figure through Dec 2025 stood at $4.2 million (down 14.42% YoY), while the FY2025 annual figure was $4.2 million, down 14.42% from the prior year.
- Other Accumulated Expenses was $4.2 million for Q4 2025 at GH Research, down from $6.2 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $6.6 million in Q3 2024 to a low of $819000.0 in Q3 2021.
- Historically, Other Accumulated Expenses has averaged $3.7 million across 5 years, with a median of $3.4 million in 2023.
- The sharpest annual moves came in 2023 and 2025: Other Accumulated Expenses soared 143.37% in 2023, then decreased 14.42% in 2025.
- A 5-year view of Other Accumulated Expenses shows it stood at $3.0 million in 2021, then fell by 10.22% to $2.7 million in 2022, then advanced by 7.09% to $2.9 million in 2023, then jumped by 72.84% to $5.0 million in 2024, then declined by 14.42% to $4.2 million in 2025.
- The last three Other Accumulated Expenses figures came in at $4.2 million (Q4 2025), $6.2 million (Q3 2025), and $6.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | GH Research | 9.73 Bn | 9.63 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.24 Mn |
| Sep 30, 2025 | 6.21 Mn |
| Jun 30, 2025 | 6.16 Mn |
| Mar 31, 2025 | 4.81 Mn |
| Dec 31, 2024 | 4.96 Mn |
| Sep 30, 2024 | 6.57 Mn |
| Jun 30, 2024 | 4.97 Mn |
| Mar 31, 2024 | 3.39 Mn |
| Dec 31, 2023 | 2.87 Mn |
| Sep 30, 2023 | 3.17 Mn |
| Jun 30, 2023 | 3.38 Mn |
| Mar 31, 2023 | 3.38 Mn |
| Dec 31, 2022 | 2.68 Mn |
| Sep 30, 2022 | 1.64 Mn |
| Jun 30, 2022 | 1.39 Mn |
| Mar 31, 2022 | 2.52 Mn |
| Dec 31, 2021 | 2.98 Mn |
| Sep 30, 2021 | 819,000.00 |